(Q35696465)

9 August 2017

title

Diuretics: drugs of choice for the initial management of patients with hypertension (English)

1 reference

9 August 2017

Flávio D Fuchs

1

1 reference

9 August 2017

publication date

1 May 2003

1 reference

Expert Review of Cardiovascular Therapy

9 August 2017

published in

1 reference

9 August 2017

volume

1

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

35-41

1 reference

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

The classics: a tribute to the fiftieth anniversary of the randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Diuretic therapy for hypertension and the risk of primary cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Cardiovascular protection and blood pressure reduction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

Diuretics: again the first step in the treatment of most patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.1.35

21 January 2018

Identifiers

DOI

10.1586/14779072.1.1.35

1 reference

9 August 2017

1 reference